Lipe & Dalton Purchases 2,100 Shares of Intel Co. (NASDAQ:INTC)

Lipe & Dalton increased its position in shares of Intel Co. (NASDAQ:INTC) by 2.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 93,383 shares of the chip maker’s stock after purchasing an additional 2,100 shares during the period. Lipe & Dalton’s holdings in Intel were worth $1,872,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Finley Financial LLC bought a new position in shares of Intel in the 4th quarter valued at $25,000. Keystone Financial Group Inc. bought a new stake in shares of Intel in the fourth quarter worth $29,000. Quest Partners LLC increased its holdings in Intel by 7,370.6% in the third quarter. Quest Partners LLC now owns 1,270 shares of the chip maker’s stock valued at $30,000 after purchasing an additional 1,253 shares during the period. West Financial Advisors LLC bought a new position in Intel during the 4th quarter worth $31,000. Finally, Groupama Asset Managment lifted its holdings in Intel by 6.3% during the 3rd quarter. Groupama Asset Managment now owns 137,181 shares of the chip maker’s stock worth $32,000 after buying an additional 8,084 shares during the period. 64.53% of the stock is currently owned by institutional investors and hedge funds.

Intel Trading Down 4.7 %

Shares of NASDAQ INTC opened at $24.87 on Friday. The company has a quick ratio of 0.98, a current ratio of 1.33 and a debt-to-equity ratio of 0.44. Intel Co. has a fifty-two week low of $18.51 and a fifty-two week high of $46.63. The firm’s 50-day simple moving average is $20.75 and its 200 day simple moving average is $21.62.

Intel (NASDAQ:INTC) last announced its earnings results on Thursday, January 30th. The chip maker reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.14). Intel had a negative net margin of 35.32% and a negative return on equity of 3.27%. As a group, research analysts forecast that Intel Co. will post -0.11 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Robert W. Baird raised their price objective on Intel from $20.00 to $25.00 and gave the stock a “neutral” rating in a research report on Friday, November 1st. Roth Mkm lowered their price target on shares of Intel from $25.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, January 31st. UBS Group dropped their target price on shares of Intel from $26.00 to $23.00 and set a “neutral” rating on the stock in a report on Tuesday, January 21st. Barclays decreased their price target on Intel from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Cantor Fitzgerald boosted their price objective on Intel from $22.00 to $29.00 and gave the company a “neutral” rating in a research note on Tuesday. Five investment analysts have rated the stock with a sell rating, twenty-seven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Intel currently has an average rating of “Hold” and an average price target of $26.88.

Intel Company Profile

Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.